𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug adherence in Parkinson's disease

✍ Scribed by Norman A. Leopold; Marcia Polansky; Marcia R. Hurka


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
57 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

:Physicians modify drug schedules in response to their patients' clinical responses. Failure to relieve patients' symptoms or the emergence of drug‐related side effects may reflect nonadherence to a prescribed drug schedule rather than incorrect therapeutic physician decisions. Using a medication questionnaire and a computerized medication event monitoring system (MEMS) to monitor medication use, nonadherence of drug use was examined in subjects with Parkinson's disease (PD). We report that prescription nonadherence in PD subjects was common and approximated that reported in other chronic diseases. During a 28‐day observation period, only 4 of 39 subjects had complete schedule adherence, i.e., no missed, extra, or mistimed doses. Using a questionnaire, 24.3% of subjects acknowledged missing any doses but the computerized MEMS recorded that 51.3% of subjects missed at least one dose per week and 20.5% of subjects missed three or more doses per week. Mistiming of doses was admitted by 73% of subjects but 82.1% had recorded mistimed doses. Of multiple sociodemographic and disease‐related items examined, only gender and level of education were statistically related to nonadherence. © 2004 Movement Disorder Society


📜 SIMILAR VOLUMES


Suboptimal medication adherence in Parki
✍ Katherine A. Grosset; Ian Bone; Donald G. Grosset 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

## Abstract Patients take less medication than prescribed in many disease areas but evidence for suboptimal therapy adherence in Parkinson's disease (PD) is limited. A single‐center observational study of antiparkinsonian medication was undertaken using electronic monitoring (MEMS; Aardex, Zug, Swi

Costs of drug treatment in Parkinson's d
✍ Dr. Richard C. Dodel; Karla M. Eggert; Marika S. Singer; Tobias E. Eichhorn; Oli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

## Abstract Parkinson's disease (PD) has a major socioeconomic impact on society. The chronic, progressive course of the disease, which often leads to severe disability, results in high expenses for the medical resources used for treatment, care, and rehabilitation of patients as well as reduced or

The association between Mediterranean di
✍ Roy N. Alcalay; Yian Gu; Helen Mejia-Santana; Lucien Cote; Karen S. Marder; Niko 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

## Abstract ## Background: Recent studies have demonstrated an association between a Mediterranean‐type diet and Alzheimer's risk. We assessed the association between Mediterranean‐type diet adherence and Parkinson's disease (PD) status. ## Methods: Two hundred and fifty‐seven PD participants an